Sirtris Pharmaceuticals

company

About

Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.

  • 51 - 100

Details

Last Funding Type
Debt Financing
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2004
Number Of Employee
51 - 100
Operating Status
Active

[Sirtris Pharmaceuticals](http://www.sirtrispharma.com) (NASDAQ: SIRT) is a biopharmaceutical company focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with aging, including metabolic diseases such as Type 2 Diabetes.

via: [Sirtris](http://www.sirtrispharma.com)

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$37M
Sirtris Pharmaceuticals has raised a total of $37M in funding over 2 rounds. Their latest funding was raised on Apr 20, 2006 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 20, 2006 Debt Financing 1 Hercules Capital Detail
Apr 19, 2006 Series C $37M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Sirtris Pharmaceuticals is funded by 2 investors. Hercules Capital and Hunt Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Debt Financing
Hunt Ventures Series C